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Background: Cameroon is one of the countries in Africa with the highest burden of Hepatitis B infection. Health
care workers are known to be at risk of occupational exposure to blood and other infectious bodily fluids. The aim
of this study was to assess the profile of serological markers of hepatitis B virus (HBV) infection, knowledge and
perceptions regarding HBV infection among health care workers in a health area in Yaoundé.
Methods: A cross-sectional study was conducted in the Mvog-Ada Health Area of the Djoungolo Health District
from March 1 to November 31, 2014. All consenting health care workers were included in the study. Serological
markers of HBV (HBs Ag, Hbe Ag, anti-HBs Ab, anti-HBe Ab, anti-HBc Ab) were qualitatively tested using
Biotech®(OneHBV-5 parameter rapid test website) in each participant and the anti-HBs antibodies were quantified
by ELISA (Biorex) among those who were positive with the qualitative test. Chi square test or its equivalents were
used to compare qualitative variables and a p-value less than or equal to 0.05 was considered significant.
Result: A total of 100 participants were retained for the study out of 163 in the health area giving a response rate of
61.34 %; the mean age was 30.5 (SD 6.8) years and 71 % of participants were women. Forty seven percent (47 %) of
workers had good level of knowledge of HBV infection. The men were 3.20 times (95 % CI: 1.02–9.19, p = 0.04) more
likely to have a good level of knowledge than women. Participants with a university study level were more (95 % CI: 3.
17–25, p < 0.0001) likely to have a good level of knowledge than those with a high school study level. Ninety-six
percent of participants thought that they were at a greater risk of becoming infected with HBV than the general
population, 93 % felt that the vaccine should be compulsory and all (100 %) were willing to recommend it to others.
However, only 19 % had received at least one dose of the vaccine. The proportion of HBs Ag was 11 %. The different
serological profiles with regard to HBV infection were naive subjects (62 %), chronic carriers (11 %), vaccinated (19 %)
and subjects naturally immunized (8 %). Three out of the 19 participants who received at least one dose of the vaccine,
only 9 (47.4 %) of whom had titers ≥100 IU/l indicating a good response to vaccination. Among those who received
three doses of the vaccine (n = 12, 63 %), 2 (16, 66 %) had poor response to vaccination (HBs Ab titers < 100 IU/l).
Conclusion: The prevalence of HBs Ag among health care workers in the Mvog-Ada Health Area is high (11 %). These
workers are at high risk of HBV infection because of very low vaccine uptake and poor post-exposure practices. Their
knowledge of HBV infection is non-optimal.
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Hepatitis B virus (HBV) infection is a major health prob-
lem worldwide owing to its high prevalence and signifi-
cant morbidity and mortality. According to a recent
systematic review and meta-analysis estimating the
worldwide prevalence of chronic HBV infection, in 2010,
about 248 million individuals were hepatitis B surface
antigen (HBs Ag) positive [1]. More than 780 000 people
die every year due to hepatitis B-related complications
including cirrhosis and hepatocellular carcinoma [2].
The prevalence of HBV chronic infection is particularly
high in Africa, prevalence reaching up to 22 % in South
Sudan [1]. In Cameroon, seroprevalence of HBs Ag has
been reported to be 10.1 % in a general population of
blood donors [3], 10.2 % among pregnant women [4]
and 23.7 % among HIV-infected patients [5].
Health care workers are at a high risk of HBV infection
through occupational exposure to blood, and the incidence
of this infection among them has been estimated to be 2–4
times the level in the general population [6]. As part of oc-
cupational safety measures, it has been recommended that
all health care workers should be vaccinated against HBV
[7]. In fact, HBV infection is preventable for more than
twenty years through effective prophylactic vaccination [8].
But intriguingly, WHO has reported that HBV vaccination
coverage amongst health care workers is only 18–39 % in
low–and middle–income countries (LMIC) compared to
67–79 % in high-income countries [9].
In Cameroon, few studies have been done on the epi-
demiology of HBV among health care providers. We pre-
viously conducted two studies among surgical residents
[10] and medical students [11] in Cameroon which
showed that despite a good knowledge of the risk factors
for HBV infection and awareness of HBV vaccine, only
24.5 % and 18 % of these respective populations were ad-
equately vaccinated against HBV. The main limitation of
these studies was the absence of serological testing to de-
termine the prevalence of HBV infection and the immune
status of participants. We therefore conducted the current
study which aimed to evaluate knowledge of HBV infec-
tion, HBV vaccine uptake, and serological profile of a
group of health care workers in Yaoundé, Cameroon.HBs Ag HBe Ag HBs Ab HBe Ab HBc Ab
Naive subjects - - - - -
Chronic carriers + - - + +
Subjects vaccinated - - + - -
Subjects naturally
immunized
- - + - +
Acute hepatitis + + - + -
+: positive - : negativeMethods
Study design, Setting and population
This was a cross-sectional study conducted from
March to November 2014 in the Mvog-Ada Health
Area, which is part of the Djoungolo Health District,
one of the eight health districts of Yaoundé, the cap-
ital city of Cameroon. This health area covers an
average population of 82,000 inhabitants and com-
prises six health facilities with a total of 163 health
care workers during the study period.Participants were health care providers working in one
of the health centers of Mvog-Ada Health Area, irrespect-
ive of their age, sex, background or seniority, who were at
their post when the investigator visited, and who voluntar-
ily accepted to take part in the study. The sample size was
calculated, considering a 6.6 % prevalence of HBs Ag car-
riage among health care workers as reported by Noah
et al. [12] in Yaoundé, and a 5 % level of precision; hence a
minimum of 96 subjects was required.Data collection and laboratory investigation
A structured pretested questionnaire was used to collect
socio-demographic information (age, sex, qualification
and year experience) and data on risk factors for HBV in-
fection among participants (practice and attitude). Upon
completion of the questionnaire, 5 ml of venous blood
was aseptically collected by venipuncture into an Ethylene
Di-amine Tetra-acetic Acid (EDTA) tube. The plasma ob-
tained from each sample was tested for serological
markers of HBV including HBs Ag, hepatitis B e antigen
(Hbe Ag), hepatitis B surface antibodies (anti-HBs Ab),
hepatitis B e antibodies (anti-HBe Ab), and hepatitis B
core antibodies (anti-HBc Ab). These tests were per-
formed using a qualitative test Biotech® (OneHBV-5 par-
ameter rapid test website, CTK Biotech, Inc. 6748 Nancy
Ridge Drive, San Diego, CA 92121, USA) in each partici-
pant, and the anti-HBs Ab were further quantified by
ELISA (Biorex Diagnostics Limited, Unit 2C Antrim
Technology Park, Muckamore; United Kingdom) among
those who were positive with the qualitative test.Assessment of knowledge on HBV and HBV vaccination
The level of knowledge of participants on HBV and HBV
vaccination was estimated using a score based on their re-
sponses to 13 questions. Each corrected answer was allo-
cated 1 point, giving a total score of 13 points. A good
level of knowledge was considered as at least 10/13. This
minimum of 10/13 defining a good level of knowledge
may seem rigorous. However, this minimum level justified
an affordable difficulty of the questions.Serological profile and immune status
The following definitions were applied [13]:
Table 1 Distribution of participants according to age, sex, level
of education and number of years of service
Characteristics Number or percentagea
Age
20–29 43
30–39 44
40–55 14
Sex
Male 29
Female 71
Level of education
Secondary 53
University 47
Qualification
Nurse aids 28
Lab technician 13
Assistant lab technician 11
Nurse 21
Midwife 7
Doctor 3
Auxiliary staff 17
Service
Laboratory 28
Maternity 19
Surgery 7
Medicine 46
Professional experience
<6 60
≥6 40
aTotal enrollment is 100, the number of the group are identical to
the percentages
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titer under 10 IU/L were considered unimmunized,
those with a titer between 10 IU/L and 100 IU/L were
considered being poorly immunized and those with a
titer equal or greater than 100 IU/L had good immunity
against HBV [14].
Data analysis
Data were coded, entered and analyzed using IBM SPSS
software (Version 20, Chicago, Illinois, USA). Results are
presented as counts (proportions) for categorical vari-
ables, and means with standard deviations (SD) for
quantitative ones. Odds ratios (OR) with their 95 % con-
fidence intervals (CI) served to investigate the influence
of various factors on the occurrence of HBV infection,
and were calculated by both univariate and multivariate
logistic regression analyses while adjusting for potential
confounders. We included in the multivariate model the
age and all variables with a p value ≤ 0.2 in univariate
analyses. For this purpose, we categorized some variables
into two groups. The age was grouped into two classes:
≤ 30 and > 30 years. Educational level was classified as
‘low’ for participant having a secondary level of educa-
tion or less, and ‘high’ for those with a University level
of education or more. Specialty was categorized as
Laboratory for “Laboratory technician, Assistant labora-
tory technician” and Medicine for “Doctor, Nurse and
Midwife”. The professional experience was dichotomized
in two groups: ≤ 6 years and > 6 years. The cut-off of
6 years was chosen because it represents the median
duration of work experience among our participants. A
p value < 0.05 was set to characterize statistically signifi-
cant results.
Results
General characteristics
Of the 163 health care workers in the health area, 100
were included in the study giving a participation rate of
61.34 %. The mean age was 30.5 (SD 6.8) years and the
male/female sex ratio was 0.40. We enrolled three doc-
tors (3 %), seven midwifes (7 %), 13 laboratory techni-
cians (13 %), 21 nurses (21 %), 28 nurse aids (28 %), 11
assistant laboratory technicians (11 %) and 17 auxiliary
staffs (17 %) (Table 1).
Level of knowledge on HBV and correlates
Forty seven participants (47 %) had a right level of
knowledge of HBV infection. Only 26 % of partici-
pants were aware that HBV is the most contagious
blood-borne virus. Most of participants correctly iden-
tified injury with contaminated needle (96 %), sexual
intercourses (96 %), mother-to-child transmission
(96 %) and blood transfusion (99 %) as routes of con-
tamination with HBV. All of them were aware of theexistence of a vaccine to prevent HBV infection, up to
77 % knew that the minimum number of doses for a
complete primary HBV vaccination is 3 doses, but
only 57 % knew that an immune response test should
be done after HBV vaccination to confirm a good
immunization status (Table 2). As shown in Table 3, in
multivariate analysis, men were 3.20 times more likely
to have a good level of knowledge than women (95 %
CI: 1.02 – 9.19, p = 0.04). Participants with a high edu-
cational level were 8.85 times more likely to have a
good level of knowledge than those with at most a
high school study level (95 % CI: 3.17-25, p < 0.0001).
Perception of HBV vaccine, vaccination status and history
of exposure to blood
Ninety-six percent of participants thought that they were
at a greater risk of becoming infected with HBV than
Table 2 Knowledge of risk factors and HBV vaccination among
100 health workers in Cameroon
Statements Correct answers
Frequency or percentage
1. HBV is the most contagious blood-borne
pathogen through accidental exposure to
blood
26
2. Contact of healthy skin with infected
blood is a risk factor of HBV infection
46
3. Injury with needle contaminated with
infected blood is a risk factor of HBV
infection
96
4. Contact of abraded skin with infected
body fluid is a risk factor of HBV infection
81
5. Contact of eyes with infected blood is a
risk factor of HBV infection
69
6. HBV could be transmitted through sexual
intercourse
96
7. HBV could be transmitted through oro-
fecal route
44
8. HBV could be transmitted through blood 99
9. HBV could be transmitted from a mother
to his foetus
96
10. Immunoglobulin against HBV can prevent
infection after exposure
39
11. There is a vaccine available against HBV 100
12. The minimum number of doses for a
complete primary HBV vaccination is 3
doses
77
13. An immune response test should be
done after HBV vaccination
57
HBV hepatitis B virus
Table 3 Unadjusted and adjusted factors associated with good kno
Variable Total Good knowledge n (%) OR (95
Age
≤30 50 22 (44) 0.46 (0
>30 50 25 (50) 1
Sex
Male 29 22 (75.86) 3.44 (1
Female 71 25 (35.21) 1
Level of education
University 47 35 (74.46) 8.20 (2
Secondary 53 12 (22.64) 1
Service
Laboratory 28 15 (53.57) 3.70 (0
Medicine 72 32 (44.44) 1
Professional experience
<6 years 60 30 (50) 0.85 (0
≥6 years 40 17 (42.50) 1
OR odds ratio, aOR adjusted odds ratio, CI confidence interval
The variables introduced in the multivariable model were age, sex and educational
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against HBV should be compulsory for all health care
workers and all of them (100 %) were willing to recom-
mend it to others colleagues. While 67 % of participants
considered the HBV vaccine as safe, only 19 % had re-
ceived at least one dose of the vaccine. Among those
who never had any dose of the HBV vaccine (n = 81), the
reasons for not being vaccinated were lack of suffi-
cient information on the vaccine (49.4 %, n = 40), lack
of money to pay for the vaccine (33.3 %, n = 27), lack
of time (12.3 %, n = 10) and lack of motivation (4.9 %,
n = 4). Moreover, 41 % of participants had been in-
formed by their training institution or by the admin-
istration of their health facility about the importance
of being vaccinated against HBV. All unvaccinated
participants were willing to receive the HBV vaccine.
Regarding history of accidental exposure, while 64 %
of participants reported occupational exposure to HBV
in the past, only 35.9 % (n = 23) of them had always noti-
fied the exposure and 75 % (n = 48) never considered the
risk of HBV infection after exposure but only the risk of
HIV infection.
Serological profile
The frequency of HBs Ag was 11 %, while that of HBs Ab
was 26 % (Table 4). Sixty-two percent of subjects were
naive to HBV and mostly females (74.2 %, n = 46). Those
working outside the laboratory (79 %, n = 49) and those
with less than 6 years of professional experience (64.5 %,
n = 40). Nineteen percent were vaccinated, mostly those
working outside the laboratory (73.7 %, n = 14), femaleswledge of HBV infection
% CI) p value aOR (95 % CI) p value
.15–1.54) 0.21 0.43 (0.16–1.2) 0.10
1
.075–1.032) 0.03 3.19 (1.02–9.91) 0.04
1
.87–23.81) <0.0001 8.85 (3.17–25) <0.0001
1
.32–42.67) 0.29
25–285) 0.79
level
Table 4 Distribution of following serological markers according to the qualification
Qualification HBs Ag positive HBs Ab positive HBe Ag positive HBe Ab positive HBc Ab positive Total
Nurse aid 3 (10.7) 6 (21.4) 0 (0) 3 (10.7) 5 (17.9) 28
Assistant Lab technician 2 (18.1) 2 (18.1) 0 (0) 2 (18.1) 2 (18.1) 11
Lan technician 4 (30.8) 5 (38.5) 0 (0) 5 (38.5) 8 (61.5) 13
Nurse 2 (9.5) 6 (28.6) 1 (4.8) 1 (4.8) 3 (14.3) 21
Doctor 0 (0) 1 (33.3) 0 (0) 0 (0) 0 (0) 3
Midwife 0 (0) 2 (28.6) 0 (0) 0 (0) 0 (0) 7
Auxiliary staff 0 (0) 4 (23.5) 0 (0) 1 (5.9) 0 (0) 17
Total 11 (11) 26 (26) 1 (100) 12 (12) 18 (18) 100
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sional experience (63.2 %, n = 12). Eight percent were nat-
urally immunized and 11 % chronic carriers (Table 5).
Serologically immunized participants (19 %) where all
those who reported having received at least one dose of
HBV vaccine. Among unvaccinated participants; 8.6 %
had the anti-Hbs ab, anti-HBc Ab and anti- Hbe Ab;
these markers reflect a natural immunity. We quanti-
fied HBs Ab and titers ranged from 0 IU/l to 251 IU/l.
Three out of the 19 participants who were vaccinated
(15.8 %) had HBs Ab titers <10 IU/l, while 7 (36.8 %)
had titers ≥10 IU/l and < 100 IU/l, and 9 (47.4 %) had
titers ≥100 IU/l indicating a good response to vaccin-
ation. Among those who received three doses of the
vaccine (n = 9), 2 had poor response to vaccination
(HBs Ab titers < 100 IU/l).Table 5 Hepatitis B serological profiles according to age, sex,
level of education, service and experience
Characteristics Naive Vaccinated Naturally
immunized
Chronic
carrier
Total
Age
≤30 33 8 1 8 50
>30 29 11 7 3 50
Sex
Male 16 7 1 5 29
Female 46 12 7 6 71
Educational level
University 28 9 4 6 47
Secondary 34 10 4 5 53
Service
Laboratory 13 5 4 6 28
Medicine 49 14 4 5 72
Experience
<6 years 40 12 1 7 60
≥6 years 22 7 7 4 40
Total 62 19 8 11 100Discussion
The current study was designed to assess knowledge of
HBV infection, HBV vaccine perception and uptake, and
determine the serological profile of a group of health care
workers in Yaoundé, Cameroon. Forty-seven percent of
the participants had a good level of knowledge on HBV
infection. After adjusting for confounders, correlates of a
good level of knowledge included male gender and high
educational level. The uptake of HBV vaccine was very
low (19 %). Serological testing showed that 62 % of partici-
pants were naïve to HBV, 10 % were chronic carriers.
Among the 19 participants who received at least one dose
of the vaccine, only 9 had a good response to vaccination.
In two previous studies, we reported good knowledge
about HBV infection among medical students [11] and sur-
gical residents [10], contrasting with the findings of the
current study which revealed that only 47 % of health care
workers had a good level of knowledge. This difference is
most likely due to the fact that participants with high edu-
cational level were about 9 times more prone to have a
right level of knowledge as had surgical residents or med-
ical students in these two previous studies, and these partic-
ipants with high educational level represented only 47 % of
the study population. This low level of knowledge is how-
ever similar to that reported among health care workers in
Northwest Ethiopia, where only 52 % of the respondents
were knowledgeable about hepatitis B infection [15].
Almost all participants (96 %) recognized that health
care workers are more at risk of being infected with
HBV than the general population, and over two-thirds of
participants considered that the vaccine against HBV is
safe. Similarly, among surgical residents and medical stu-
dents in Cameroon, we found that respectively 78.4 % of
participants and 97.3 % thought that the HBV vaccine
was safe and 87.4 %, and 78.4 % recognized that HCW
were more at risk [10, 11]. Our participants felt that vac-
cination should be mandatory for health care providers
(93 %) and all (100 %) participants agreed to recommend
HBV vaccination to their colleague. However, only 19 %
were vaccinated.
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our previous studies among surgical residents (24.5 %)
[10] and medical students (18 %) [11], and in another
study among health care workers in Yaoundé (8.8 %)
[12]. Among health profession trainees, HBV vaccine
coverage was reported to be 47.7 % among medical stu-
dents [16] and 37.9 % among dental students in Nigeria
[17], 76.8 % among medical students and 46.7 % among
interns in Palestine [18]. A study among theatre
personnel in Nigeria reported a HBV uptake rate of
26.8 % [19], while 5.4 % and 52 % of health care
workers respectively in Northwest Ethiopia [15] and
Libya [20] reported that they took three or more doses
of HBV vaccine.
Studies have shown that awareness of risk among
health care workers is an important factor affecting HBV
vaccine uptake [21–23]. Contrariwise, the low vaccine
coverage among our participants contrasts with the fact
that almost all of them (96 %) considered that they are
at a higher risk of HBV infection than the general popu-
lation. The main reason of this low vaccine uptake was
reported to be lack of sufficient information on the vac-
cine. This reason is in keeping with the fact that only
41 % of participants had been informed by their training
institution or by the administration of their health facil-
ity about the importance of being vaccinated against
HBV. Therefore, raising the awareness of health care
workers about the importance of being vaccinated
against HBV and providing them with relevant informa-
tion about HBV vaccine is paramount to scale up
vaccine uptake in this population at high risk of HBV
infection.
Another important reason of not being vaccinated was
lack of money to pay for the vaccine. This stresses the
need to subsidize HBV vaccination among health care
workers. Considering the fact that HBV vaccine is freely
provided to children inside the national Expanded
Programme for immunization (EPI) since 2005, our
health care system should afford subsidizing the vaccine
for health care workers bearing in mind their high risk
of being contaminated by or to contaminate their pa-
tients. Indeed, there is an urgent need for health policies
advocating HBV vaccination among health care workers
in Cameroon in order to curb the burden and occupa-
tional risk of HBV infection in the hospital environment.
Furthermore, we found that only 9 out of the 19
participants who were vaccinated had HBs Ab titers
≥100 IU/l indicating a good response to vaccination. In
fact, only 9 % of our study population was adequately
vaccinated and thus protected against HBV infection.
Among the 9 participants who said they took three
doses of the vaccine, 2 had poor response to vaccination
(HBs Ab titers < 100 IU/l), highlighting the necessity to
do an immune response test after the 3 doses of theminimum HBV vaccination course, in order to have a
booster dose in case of poor immune response.
The prevalence of HBs Ag in our study population was
11 %, with 10 % chronic carriers and 1 % of active HBV in-
fection. These health care workers may develop fatal com-
plications such as cirrhosis and hepatocellular carcinoma.
These workers can also potentially transmit HBV to their
patients. In Cameroon, seroprevalence of HBs Ag has
been reported to be 10.1 % in a general population of
blood donors [3], 10.2 % among pregnant women [4] and
23.7 % among HIV-infected patients [5]. Among health
care workers, a study in Yaoundé reported a prevalence of
6.6 % lower than what we found [12]. Among health care
workers the rate of HBs Ag positivity was 1.8 % in a study
in Libya [20], 2.9 % in Rwanda [24], 7 % in Tanzania [25]
and 8.1 % in Uganda [26]. The higher frequency of HBV
infection in our study as compared to those from other
countries is mainly due to the high prevalence of the in-
fection in the general population.
Finally, 62 % of our participants had never been ex-
posed to HBV and therefore susceptible or at risk of
HBV infection. These subjects highly need vaccination
to be protected. The importance of vaccination is
highlighted by the very poor preventive practices of par-
ticipants after exposure to blood. Indeed, those exposed
did not notify the exposure to the authorities in their
health facilities, to seek post-exposure prophylaxis.
Moreover, the majority (75 %) initially only considered
the risk of HIV infection and only 25 % considered that
of HBV infection. This could be due to the fact that, in
most public health awareness campaigns, a lot of
emphasis is made on HIV/AIDS, leading to greater con-
sciousness on HIV in the general population and among
health care workers as opposed to HBV despite its high
infectivity. While it is important to improve attitudes to-
wards post-exposure prophylaxis, vaccination against
HBV remains overriding.
Conclusion
Health care workers in the Mvog-Ada Health Area are
at high risk of HBV infection because of very low vac-
cine uptake and poor post-exposure practices. Their
knowledge of HBV infection is non-optimal, with lack of
information and support regarding HBV vaccination.
The prevalence of HBs Ag is high (11 %). There is ur-
gent need for health policies advocating HBV vaccin-
ation among health care workers in Cameroon in order
to curb the burden and occupational risk of HBV infec-
tion in the hospital environment.
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